Description
C-82 is an active metabolite of PRI-724 and is an inhibitor of beta-catenin. Endometriotic cyst stromal cells treated with C-82 in vitro showed inhibited cell growth, cell migration, and fibrosis.
| Product Unit Size | Cost | Quantity | Stock |
|---|
C-82 is an active metabolite of PRI-724 and is an inhibitor of beta-catenin. Endometriotic cyst stromal cells treated with C-82 in vitro showed inhibited cell growth, cell migration, and fibrosis.
| Cas No. | 1422253-37-9 |
|---|---|
| Purity | ≥99% |
| Formula | C33H34N6O4 |
| Formula Wt. | 578.67 |
| IUPAC Name | (6S,9S,9aS)-N-benzyl-6-(4-hydroxybenzyl)-2,9-dimethyl-4,7-dioxo-8-(quinolin-8-ylmethyl)hexahydro-2H-pyrazino[2,1-c][1,2,4]triazine-1(6H)-carboxamide |
| Synonym | C 82, C82 |
| Appearance | White crystalline powder |
| Store Temp | -20°C |
|---|---|
| Ship Temp | Ambient |
| Info Sheet |
|---|
Hirakawa T, Nasu K, Miyabe S, et al. beta-catenin signaling inhibitors ICG-001 and C-82 improve fibrosis in preclinical models of endometriosis. Sci Rep. 2019 Dec 27;9(1):20056. PMID: 31882904
Lafyatis R, Mantero J, Gordon J, et al. Inhibition of beta-catenin signaling in the skin rescues cutaneous adipogenesis in systemic sclerosis: a randomized, double-blind, placebo-controlled trial of C-82. J Invest Dermatol. 2017 Dec;137(12):2473-2483. PMID: 28807667
Cell-penetrating peptide, carries large conjuga...
Melatonin analog; MT1/2 agonist, 5-HT2C antagon...
GHB/GABA analog found in Valeriana officinalis;...
α1-adrenergic agonist.
Bosutinib isomer; Src and Abl inhibitor.
Benzimidazole; microtubule polymerization inhib...
Inhibitor of CDK.
Aminoglycoside; protein translation inhibitor.<...
Endogenous peptide hormone, counteracts insulin...
CB1 agonist, TRPV1 agonist.
Dithiolopyrrolone; RNA polymerase inhibitor.
Pyrimidine nucleoside (cytidine) analog; DNA ch...
Inert clozapine analog, activates specialized G...
Pentacyclic triterpene found in various plant s...
Folic acid derivative
Smac mimetic; IAP inhibitor.
EZH2 HMT inhibitor.
Peptide, involved in neutrophil activation; FPR...
pan-Bcr-Abl tyrosine kinase inhibitor.
SIRT2 inhibitor.